More recently, a retrospective cohort study in 145 transplant recipients with KS reported that, although conversion to mTor inhibitors is more likely in patients with systemic involvement, reduction of immunosuppression along with a switch to mTor inhibitors allows KS to stabilize or respond in most patients [24]. Here, MTOR is linked to Kaposi's sarcoma.